Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

COVID-19 Vaccination: Third Doses and Boosters

The ever-evolving COVID-19 vaccination landscape has created many questions about who should receive additional vaccine doses, when, and why. Hear expert faculty discuss COVID-19 vaccination efficacy, the rationale for third doses and booster doses, and the data behind mixing and matching of booster doses.
Renslow Sherer, MD
Released: December 10, 2021

In this episode, Renslow Sherer, MD, discusses key data on COVID-19 vaccine efficacy, including:

  • Third doses
  • Booster doses
  • Mixing and matching booster doses

Information on this Educational Activity

Faculty

Renslow Sherer, MD

Director, International HIV Training Center
Professor of Medicine
Section of Infectious Diseases and Global Health
Department of Medicine
University of Chicago
Chicago, Illinois

Renslow Sherer, MD, has disclosed that he has received funds for research support from Gilead Sciences.

Program Medium

This program has been made available online.

Acknowledgements

Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
Gilead Sciences, Inc.
Janssen Therapeutics, Division of Janssen Products, LP
Merck Sharp & Dohme Corp.

Related Content

Expert summaries of COVID-19 testing, risk stratification, treatment options, and long COVID, from Clinical Care Options (CCO), Practicing Clinicians Exchange (PCE), and ProCE.

Jason E. Farley, PhD, MPH, ANP-BC, FAAN, FAANP, AACRN Renslow Sherer, MD person default Trinh P. Vu, PharmD, BCIDP Released: October 6, 2022

This downloadable PDF reviews COVID-19 diagnostic testing and risk stratification of patients who test positive, from Clinical Care Options (CCO), PCE (Practicing Clinicians Exchange), and ProCE

Renslow Sherer, MD Released: October 3, 2022

Trinh P. Vu, PharmD, BCIDP: management of COVID-19 in the outpatient setting using oral antiviral agents, from Clinical Care Options (CCO)

person default Trinh P. Vu, PharmD, BCIDP Released: September 28, 2022

Josep M. Llibre, MD, PhD: antivirals for all adults aged 65 years and older with early COVID-19, from Clinical Care Options (CCO)

Josep M. Llibre, MD, PhD Released: September 22, 2022

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings